Streetbeat News

Price Targets

NTLA

Cantor Fitzgerald analyst Rick Bienkowski has reiterated an Overweight rating on Intellia Therapeutics (NASDAQ:NTLA) and maintained a $65 price target.

Portfolio Pulse from richadhand@benzinga.com

August 29, 2023 | 3:41 pm

EDIT

Cantor Fitzgerald analyst Rick Bienkowski has reiterated an Overweight rating on Editas Medicine (NASDAQ:EDIT) and maintained a $14 price target.

Portfolio Pulse from richadhand@benzinga.com

August 29, 2023 | 3:40 pm

BEAM

Cantor Fitzgerald analyst Rick Bienkowski has reiterated an Overweight rating on Beam Therapeutics (NASDAQ:BEAM) and maintained a $56 price target.

Portfolio Pulse from richadhand@benzinga.com

August 29, 2023 | 3:39 pm

GOGL

Jefferies analyst Omar Nokta has maintained a 'Hold' rating on Golden Ocean Group (NASDAQ:GOGL) and lowered the price target from $8.5 to $8.

Portfolio Pulse from richadhand@benzinga.com

August 29, 2023 | 3:26 pm

CLNN

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Clene (NASDAQ:CLNN) and maintained a $7 price target.

Portfolio Pulse from richadhand@benzinga.com

August 29, 2023 | 3:25 pm

CYBN

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Cybin (AMEX:CYBN) and maintained a $10 price target.

Portfolio Pulse from richadhand@benzinga.com

August 29, 2023 | 3:24 pm

ORCL

Oracle's stock has been upgraded from Neutral to Buy by UBS, with the price target raised from $120 to $140. This has resulted in Oracle shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 3:23 pm

BBAI

HC Wainwright has initiated coverage on BigBear.Ai with a Buy rating and a price target of $4, leading to an increase in the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 3:01 pm

ASO

TD Cowen analyst John Kernan maintains an Outperform rating on Academy Sports (NASDAQ:ASO) but lowers the price target from $68 to $65.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 3:00 pm

ITT

TD Cowen analyst Joseph Giordano maintains an Outperform rating on ITT (NYSE:ITT) and raises the price target from $100 to $105.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 2:59 pm